Long-term insulin requirement after liver transplantation with FK 506 in American veterans.
作者信息
Tabasco-Minguillan J, Mieles L, Carroll P, Gavaler J, Van Thiel D H, Starzl T E
机构信息
Department of Gastroenterology and Hepatology, University of Pittsburgh, PA 15261.
出版信息
Transplant Proc. 1993 Feb;25(1 Pt 1):677-8.
Abstract
摘要
相似文献
1
Long-term insulin requirement after liver transplantation with FK 506 in American veterans.美国退伍军人肝移植后使用FK 506的长期胰岛素需求情况。
Transplant Proc. 1993 Feb;25(1 Pt 1):677-8.
2
Insulin requirements after liver transplantation and FK-506 immunosuppression.肝移植及使用FK-506免疫抑制后的胰岛素需求情况。
Transplantation. 1993 Oct;56(4):862-7. doi: 10.1097/00007890-199310000-00017.
3
Disappearance of diabetes mellitus after conversion from FK 506 to Neoral in two liver transplanted patients.
Transplant Proc. 1998 Aug;30(5):1863-4. doi: 10.1016/s0041-1345(98)00461-8.
4
Diabetes mellitus after renal transplantation under FK 506 (tacrolimus) as primary immunosuppression.
Transplant Proc. 1996 Jun;28(3):1304-5.
5
A randomized trial of primary liver transplantation under immunosuppression with FK 506 vs cyclosporine.一项关于在免疫抑制下使用FK 506与环孢素进行原位肝移植的随机试验。
Transplant Proc. 1991 Dec;23(6):2977-83.
6
Optimizing glycemic control with insulin glargine.使用甘精胰岛素优化血糖控制。
Diabetes Technol Ther. 2003;5(3):471-3. doi: 10.1089/152091503765692009.
7
Tacrolimus reduction improves glucose metabolism and insulin secretion after liver transplantation.肝移植后降低他克莫司剂量可改善糖代谢及胰岛素分泌。
Transplant Proc. 1996 Dec;28(6):3180-2.
8
Liver transplantation of American veterans under FK 506 immunosuppression: a preliminary report.接受FK 506免疫抑制治疗的美国退伍军人肝移植：初步报告。
Transplant Proc. 1991 Dec;23(6):3016-8.
9
Four-hour versus 24-hour intravenous infusion of FK 506 in liver transplantation.肝移植中FK 506的4小时与24小时静脉输注
Transplant Proc. 1991 Dec;23(6):2767-70.
10
Adverse effects of FK 506 overdosage after liver transplantation.肝移植后FK 506过量的不良反应。
Transplant Proc. 1993 Feb;25(1 Pt 1):628-34.
引用本文的文献
1
Tacrolimus. A review of its pharmacology, and therapeutic potential in hepatic and renal transplantation.他克莫司。其药理学及在肝移植和肾移植中的治疗潜力综述。
Drugs. 1993 Oct;46(4):746-94. doi: 10.2165/00003495-199346040-00009.
本文引用的文献
1
FK 506 for liver, kidney, and pancreas transplantation.用于肝脏、肾脏和胰腺移植的FK 506。
Lancet. 1989 Oct 28;2(8670):1000-4. doi: 10.1016/s0140-6736(89)91014-3.
2
A highly sensitive method to assay FK-506 levels in plasma.一种检测血浆中FK-506水平的高灵敏度方法。
Transplant Proc. 1987 Oct;19(5 Suppl 6):23-9.
3
FK 506-associated diabetes mellitus in the pediatric transplant population is a rare complication.儿童移植人群中与FK 506相关的糖尿病是一种罕见的并发症。
Transplant Proc. 1991 Dec;23(6):3171-2.
4
New onset of diabetes in FK 506 vs cyclosporine-treated kidney transplant recipients.接受他克莫司（FK 506）与环孢素治疗的肾移植受者新发糖尿病情况。
Transplant Proc. 1991 Dec;23(6):3169-70.
5
Adverse effects associated with the use of FK 506.与使用FK 506相关的不良反应。
Transplant Proc. 1991 Dec;23(6):3105-8.
6
A randomized trial of primary liver transplantation under immunosuppression with FK 506 vs cyclosporine.一项关于在免疫抑制下使用FK 506与环孢素进行原位肝移植的随机试验。
Transplant Proc. 1991 Dec;23(6):2977-83.
7
Notes on FK 506.关于FK 506的笔记。
Transplant Proc. 1991 Aug;23(4):2178-9.
8
Current status of FK 506 in liver transplantation.FK506在肝移植中的现状。
Transplant Proc. 1991 Jun;23(3):1902-5.
9
Glycemia and insulin need following FK 506 rescue therapy in liver transplant recipients.肝移植受者接受FK 506挽救治疗后的血糖水平和胰岛素需求情况。
Transplant Proc. 1991 Feb;23(1 Pt 2):949-53.
10
One hundred ten consecutive primary orthotopic liver transplants under FK 506 in adults.110例成人在使用FK 506情况下进行的连续原位肝移植。
Transplant Proc. 1991 Feb;23(1 Pt 2):1397-402.
Zotero 插件